Articles by Tom Valeo

1 2 3 4 5

NIH StrokeNet: How the NINDS is improving and accelerating clinical trials for stroke.

Valeo, Tom

Neurology Now. 10(2):36-38, April/May 2014.

How the National Institutes of Health Stroke Trials Network is revolutionizing clinical trials and improving stroke care.

Picture the Brain: New brain-imaging techniques provide better ways to diagnose and treat neurologic conditions.

Valeo, Tom

Neurology Now. 9(5):28-30, October/November 2013.

Until the last couple of decades, neurologists could only observe the consequences of Alzheimer's disease (AD)—and then examine the brain at autopsy. Today, a variety of brain-imaging techniques are providing neurologists with vivid pictures of the brain at work. In turn, these images are opening up new ways to diagnose and treat AD and many other neurologic conditions.

This Way In: Navigating Life With Parkinson Disease

Valeo, Tom

Neurology Now. 8(6):13, December-january 2012.

This Way In: A sneak peek at Navigating Life With Parkinson Disease, new from the American Academy of Neurology's Neurology Now™ Books for patients and caregivers.

Not Just Tremor: Recognizing depression and other non-motor symptoms of Parkinson's disease.

Valeo, Tom

Neurology Now. 8(6):22-27, December-january 2012.

Parkinson's disease (PD) is commonly associated with visible motor symptoms—tremor, slow movement, and rigidity. But its many non-motor symptoms, such as depression and anxiety, may be harder to detect. “Patients and caregivers feel the burden of these non-motor symptoms,” says Dr. Christopher G. Goetz. Read on for more information about the non-motor symptoms of PD, treatment options, and emerging research.

Searching for the Early Signs of Alzheimer's Disease

Valeo, Tom

Neurology Now. 8(5):34-35, October-november 2012.

The Alzheimer's Disease Neuroimaging Initiative could be a landmark study—if enough people volunteer.

University of Google: How to find trustworthy medical information online.

Valeo, Tom

Neurology Now. 7(5):64-65, October-November 2011.

Answers to readers' questions about plasmapheresis for myasthenia gravis, Moyamoya disease, and the effects of radiation on the brain and spinal cord.

Choosing to Enroll, or Not: Weighing the costs and benefits of joining an experimental drug trial.

Valeo, Tom

Neurology Now. 7(5):69-70,72, October-November 2011.

When two of their daughters were diagnosed with the rare, life-threatening condition called Batten disease, Kathy and Joe Allio had to weigh the pros and cons of joining an experimental trial.

Of Doctors and Data: In recommending treatments, neurologists must combine the best available evidence with their clinical judgment. What does this mean for you?

Valeo, Tom

Neurology Now. 6(6):27-30, November-December 2010.

In recommending treatments, neurologists must do more than rely on what their predecessors did: They must combine the best available evidence with their clinical judgment. But what does this mean for you? Top neurologists explain how “evidence-based medicine” can help you get better care.

The “Other” Dementias


Neurology Now. 5(6):26-27,31-34, November-December 2009.

Everyone has heard of Alzheimer's, which accounts for 65 percent of all dementia in the United States. But more than 100 causes of dementia exist. Here, we take a look at the “big four”: Alzheimer's, frontotemporal dementia, Lewy body dementia, and vascular dementia. Knowing them may help you or your loved one get the right treatment.

1 2 3 4 5